arrow
返回
S

Si Shi

Sun Yat-Sen University

58H指数
344论文数
1.4W被引数
收录论文 139
发表时间
A programmable living force sensor fabricated with surface engineered microbial network通过表面工程化微生物网络制备的可编程生物力传感器
err2026-07-23
err0
errOAAI
errSi Shi; Changhong Wang; Qiliner Feng; Hailin Li; Aike Shi; Jie Liu; Yongzheng Ma; Xiangjun Gong; Zifu Li; Baizhu Chen
err分享
err收藏
Multi-label dynamic diagnosis of pancreatic diseases using AI-enhanced endoscopic ultrasound: a multi-cohort real-world study基于AI增强内镜超声的胰腺疾病多标签动态诊断:一项多队列真实世界研究
err2026-06-17
err0
PREAI
errKe Chen; Kai Zhang; Chunbing Zhu; Chao Zhang; Xiangpeng Hu; Zhixi Li; Jing Du; Qianqian Fang; Qijie Rui; Jianwei Qi; Bin Yao; Lingyu Zhang; Liting Zhang; Yuan Liu; Jin Xu; Xianjun Yu; Si Shi
err分享
err收藏
The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy二硫键断裂细胞凋亡在代谢协同性死亡和癌症免疫治疗中的新兴作用
err2026-06-02
err0
errOAAI
errZheng Wu; Rong Tang; Jin Xu; Yufeng Wang; Liquan Jin; Yingna Liao; Dingru Li; Cheng Zu; Chengkai Yang; Xianjun Yu; Si Shi
err分享
err收藏
Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer胰腺癌肿瘤微环境的代谢特征调控治疗策略和临床结局
err2026-05-28
err0
errOAAI
errRong Tang; Yangyi Li; Cong Zhou; Chunbin Zhu; Chen Chen; Liquan Jin; Yueyue Chen; Yingna Liao; Yuan Liu; Qiong Du; Yubin Lei; Zijian Wu; Jin Xu; Wei Wang; Xiaoyu Yin; Chenghao Shao; Si Shi; Xianjun Yu
err分享
err收藏
err分享
err收藏
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer一项关于APG-1387(一种IAP拮抗剂)联合nab-紫杉醇和吉西他滨治疗难治性转移性胰腺癌的Ⅰ期临床试验
err2025-09-19
err0
errOAAI
errSi Shi; Jian Zhang; Rujiao Liu; Shuiping Gao; Jin Xu; Wei Wang; Miaoyan Wei; Jialin Li; Chen Liu; Xiaowu Xu; Wentao Pan; Xiaohong Tian; Lichuang Men; Hengbang Wang; Zhiyan Liang; Min Zhu; Dajun Yang; Yifan Zhai; XianJun Yu
err分享
err收藏
Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma (vol 22, 365, 2024)胰腺腺癌中,将fuzuloparib联合改良FOLFIRINOX作为一线治疗,随后进行fuzuloparib维持单药治疗的Phase 1b研究(卷22,365,2024)
err2025-04-14
err0
errOAAI
errWei, Miaoyan; Liu, Rujiao; Xu, Yunyun; Chen, Xiaobing; Liu, Chao; Bai, Xueli; Zhang, Xiaochen; Gao, Shuiping; Li, Jialin; Sheng, Zhen; Lian, Jianpo; Wang, Wenliang; Zhang, Jian; Shi, Si; Xu, Jin; Yu, Xianjun
err分享
err收藏
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosis新型GSDMD抑制剂GI-Y2发挥抗焦亡作用以减轻动脉粥样硬化
err2025-03-05
err0
errOAAI
errFan, Xiaoxi; Cheng, Zhenfeng; Shao, Ruiyin; Ye, Keke; Chen, Xudong; Cai, Xueli; Dai, Shanshan; Tang, Zhixuan; Shi, Si; Zheng, Wenyuan; Huang, Weijian; Han, Jibo; Ye, Bozhi
err分享
err收藏
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers
err2025-01-17
err0
errOAAI
errLu, Zhihao; Geng, Mingfei; Han, Yongtao; Cao, Jianzhong; Wang, Jun; Liu, Tianshu; Yuan, Xianglin; Meng, Xue; Zhang, Yanqiao; Zhao, Rong; Wan, Lixin; Li, Enxiao; Wang, Wenran; Li, Zhijie; Shi, Danfeng; Qian, Jing; Shi, Si; Dong, Fengshi; Shen, Lin
err分享
err收藏
err分享
err收藏